Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

NCT00595465 ·Status: COMPLETED ·Phase: PHASE3

Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

NCT00595270 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling

NCT00776230 ·Status: COMPLETED ·Phase: PHASE3

Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination

NCT01559831 ·Status: WITHDRAWN ·Phase: PHASE1

Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440

NCT00596271 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries

NCT01047839 ·Status: COMPLETED ·Phase: PHASE3

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

NCT01246479 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population

NCT01041573 ·Status: COMPLETED ·Phase: PHASE3

Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children

NCT01954810 ·Status: UNKNOWN ·Phase: PHASE4

Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country

NCT01296360 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis

NCT06825312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants

NCT00480324 ·Status: COMPLETED ·Phase: PHASE3

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

NCT04817917 ·Status: UNKNOWN ·Phase: PHASE4

Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers

NCT01001988 ·Status: COMPLETED ·Phase: PHASE3

Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas

NCT06678373 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

NCT00621764 ·Status: COMPLETED ·Phase: PHASE2

6-year Antibody Check After Third Vaccination Against Japanese Encephalitis

NCT02039440 ·Status: COMPLETED ·Phase: PHASE4

A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)

NCT00835380 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine

NCT02602652 ·Status: COMPLETED ·Phase: NA

Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

NCT00412516 ·Status: COMPLETED ·Phase: PHASE3

A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers

NCT01092507 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

NCT04648241 ·Status: COMPLETED ·Phase: PHASE3

Purified Inactivated Japanese Encephalitis Vaccine

NCT04223037 ·Status: UNKNOWN ·Phase: PHASE3

Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children

NCT01408537 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

NCT05065177 ·Status: COMPLETED ·Phase: PHASE3